Read More Pharma Industry News How the Nautilus Biotechnology and Michael J. Fox Foundation alliance signals a shift in Parkinson’s biomarker strategy (NASDAQ: NAUT) Find out how Nautilus Biotechnology’s Parkinson’s collaboration signals a strategic shift in biomarker platforms and what it means for investors and drug developers. bySoujanya RaviJanuary 31, 2026